BURLINGTON, Mass., Sept. 30, 2008 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, announced today that it will present at The Third Annual JMP Securities Healthcare Focus Conference being held at the Le Parker Meridien in New York City on Tuesday, October 7, 2008.
George W. LeMaitre, Chairman and Chief Executive Officer, and David B. Roberts, President, will provide an update on the company at 12:30 pm Eastern Time.
A live audio webcast of the presentation will be available via the Internet at http://www.lemaitre.com/investor and will be available for replay for approximately 30 days.
About LeMaitre Vascular
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.